Next-Generation Orphan Drug Delivery

Summary: According to the National Organization for Rare Disorders (NORD), a disease is rare if it affects fewer than 200,000 Americans. There have been around 6,800 rare diseases defined so far, affecting around 30 million people in the US alone. Big Pharma used to ignore this segment of the market, but now developing orphan drugs to treat these rare diseases is an industry priority.

Download it Now

お問い合わせ

    東京オフィス
    〒107‐0052
    東京都港区赤坂4−9−17
    T (03) 3470-2311
    F (03) 3408-5554

    掛川工場
    〒436‐0341
    静岡県掛川市倉真1656
    T(0537) 29-1131